Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 août 2011 08h00 HE | Source: BG Medicine Inc.

BG Medicine Announces Fiscal 2011 Second Quarter Results

WALTHAM, Mass., Aug. 11, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the three and six months ended June 30, 2011, and provided...
02 août 2011 08h30 HE | Source: BG Medicine Inc.

New Studies on Role of Galectin-3 in Heart Failure to be Presented at European Society of Cardiology (ESC) Congress 2011

WALTHAM, Mass., Aug. 2, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that...
01 août 2011 16h30 HE | Source: BG Medicine Inc.

BG Medicine, Inc. Announces Peer-Reviewed Publication on High-Risk Plaque (HRP) Initiative and BioImage Study

WALTHAM, Mass., Aug. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today the...
01 août 2011 08h00 HE | Source: BG Medicine Inc.

BG Medicine, Inc. to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable

WALTHAM, Mass., Aug. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that...
28 juil. 2011 08h00 HE | Source: BG Medicine Inc.

BG Medicine Announces Second Quarter 2011 Financial Results Release Date and Conference Call Information and Automatic Extension of IPO Lock-Up Agreements

WALTHAM, Mass., July 28, 2011 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the second quarter of fiscal year 2011 will be released prior to the...
27 juil. 2011 08h00 HE | Source: BG Medicine Inc.

BG Medicine, Inc. Appoints Stephane Bancel as Executive Chairman of the Board

WALTHAM, Mass., July 27, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
18 juil. 2011 16h30 HE | Source: BG Medicine Inc.

BG Medicine Inc. Receives ISO 13485 Certification

WALTHAM, Mass., July 18, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
28 juin 2011 08h30 HE | Source: BG Medicine Inc.

BG Medicine, Inc. Names Stephen R. Miller Chief Commercial Officer

WALTHAM, Mass., June 28, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a life sciences company focused on the discovery, development, and commercialization of novel, biomarker-based...
03 juin 2011 17h00 HE | Source: BG Medicine Inc.

BG Medicine to Present at the Jefferies 2011 Global Healthcare Conference

WALTHAM, Mass., June 3, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that it will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011 at...
12 mai 2011 07h00 HE | Source: BG Medicine Inc.

BG Medicine Announces Fiscal 2011 First Quarter Results

WALTHAM, Mass., May 12, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the first quarter of fiscal year 2011 and provided a...

Page suivante